Assessing biosimilarity and interchangeability of biosimilar products.
Publication
, Journal Article
Chow, S-C
Published in: Stat Med
February 10, 2013
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Stat Med
DOI
EISSN
1097-0258
Publication Date
February 10, 2013
Volume
32
Issue
3
Start / End Page
361 / 363
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Therapeutic Equivalency
- Statistics & Probability
- Patents as Topic
- Government Regulation
- Drug Approval
- Biosimilar Pharmaceuticals
- 4905 Statistics
- 4202 Epidemiology
Citation
APA
Chicago
ICMJE
MLA
NLM
Chow, S.-C. (2013). Assessing biosimilarity and interchangeability of biosimilar products. Stat Med, 32(3), 361–363. https://doi.org/10.1002/sim.5577
Chow, Shein-Chung. “Assessing biosimilarity and interchangeability of biosimilar products.” Stat Med 32, no. 3 (February 10, 2013): 361–63. https://doi.org/10.1002/sim.5577.
Chow S-C. Assessing biosimilarity and interchangeability of biosimilar products. Stat Med. 2013 Feb 10;32(3):361–3.
Chow, Shein-Chung. “Assessing biosimilarity and interchangeability of biosimilar products.” Stat Med, vol. 32, no. 3, Feb. 2013, pp. 361–63. Pubmed, doi:10.1002/sim.5577.
Chow S-C. Assessing biosimilarity and interchangeability of biosimilar products. Stat Med. 2013 Feb 10;32(3):361–363.
Published In
Stat Med
DOI
EISSN
1097-0258
Publication Date
February 10, 2013
Volume
32
Issue
3
Start / End Page
361 / 363
Location
England
Related Subject Headings
- United States Food and Drug Administration
- United States
- Therapeutic Equivalency
- Statistics & Probability
- Patents as Topic
- Government Regulation
- Drug Approval
- Biosimilar Pharmaceuticals
- 4905 Statistics
- 4202 Epidemiology